Minna M. Hankaniemi

Pl 100
Tampere, 33014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity.

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity.

Journal: Journal of biomedical science

Published: December 09, 2025

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.

Journal: BMC infectious diseases

Published: November 21, 2025

Quantitative virus infectivity titration and dose-response analyses using cell-culture based methods and python code-assisted data analysis.

Quantitative virus infectivity titration and dose-response analyses using cell-culture based methods and python code-assisted data analysis.

Journal: iScience

Published: September 08, 2025

Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice.

Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice.

Journal: Journal of biomedical science

Published: June 18, 2025

Immunological and structural evaluation of the intranasally administrated CVB1 whole-virus and VLP vaccines.

Immunological and structural evaluation of the intranasally administrated CVB1 whole-virus and VLP vaccines.

Journal: Scientific reports

Published: December 05, 2024

Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates.

Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates.

Journal: Research square

Published: July 09, 2024

Experimental VLP vaccine displaying a furin antigen elicits production of autoantibodies and is well tolerated in mice.

Experimental VLP vaccine displaying a furin antigen elicits production of autoantibodies and is well tolerated in mice.

Journal: Nanoscale advances

Published: June 11, 2024

Enteroviruses: epidemic potential, challenges and opportunities with vaccines.

Enteroviruses: epidemic potential, challenges and opportunities with vaccines.

Journal: Journal of biomedical science

Published: March 14, 2024

Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression.

Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression.

Journal: Scientific reports

Published: January 29, 2024

SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.

SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.

Journal: Frontiers in cellular and infection microbiology

Published: May 03, 2023

Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination.

Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination.

Journal: iScience

Published: June 10, 2022

Rapid high-throughput compatible label-free virus particle quantification method based on time-resolved luminescence.

Rapid high-throughput compatible label-free virus particle quantification method based on time-resolved luminescence.

Journal: Analytical and bioanalytical chemistry

Published: February 13, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026